Voyager Therapeutics share price today

(VYGR)

Voyager Therapeutics share price is $5.75 & ₹488.61 as on 21 Dec 2024, 2.30 'hrs' IST

$5.75

▲

0.06

(1.05%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Voyager Therapeutics share price in Dollar and Rupees. Guide to invest in Voyager Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Voyager Therapeutics. Get details on the Indian mutual funds that are investing in Voyager Therapeutics. Get Analyst recommendations and forecasts along with all the Voyager Therapeutics's financials.

Voyager Therapeutics share price movements

Today's Low: $5.53
Today's High: $5.87
$5.75
3.84%
Downside
Day's Volatility :5.8%
Upside
2.04%
52 Weeks Low: $5.19
52 Weeks High: $11.72
$5.75
9.74%
Downside
52 Weeks Volatility :55.72%
Upside
50.94%

Voyager Therapeutics Returns

Period	Voyager Therapeutics, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-6.72%	-12.2%	0.0%
6 Months	-29.36%	-6.9%	0.0%
1 Year	-32.9%	2.7%	0.0%
3 Years	97.57%	-0.2%	-17.3%

Voyager Therapeutics Key Statistics

in dollars & INR

Previous Close	$5.69
Open	$5.69
Today's High	$5.87
Today's Low	$5.5294
Market Capitalization	$316.3M
Today's Volume	$458.1K
52 Week High	$11.72
52 Week Low	$5.19
Revenue TTM	$163.8M
EBITDA	$14.1M
Earnings Per Share (EPS)	$0.66
PE Ratio	8.77
Profit Margin	15.8%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	10.22%

How to invest in Voyager Therapeutics from India?

It is very easy for Indian residents to invest directly in Voyager Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Voyager Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Voyager Therapeutics or VYGR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Voyager Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Voyager Therapeutics shares which would translate to 0.148 fractional shares of Voyager Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Voyager Therapeutics, in just a few clicks!

Returns in Voyager Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

Voyager Therapeutics investment value today

Current value as on today

₹1,34,289

Returns

₹34,289

(+34.29%)

Returns from Voyager Therapeutics Stock

₹32,193 (false-32.19%)

Dollar Returns

₹2,095 (+2.1%)

Indian investors sentiment towards Voyager Therapeutics

500%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Voyager Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 500% more investors are searching Voyager Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Voyager Therapeutics

BlackRock Inc
9.73%
Armistice Capital, LLC
9.52%
EcoR1 Capital, LLC
7.17%
Vanguard Group Inc
5.83%
Farallon Capital Management, L.L.C.
4.20%
Great Point Partners LLC
2.93%

Analyst Recommendation on Voyager Therapeutics

Buy

87%Buy

12%Hold

0%Sell

Based on 16 Wall street analysts offering stock ratings for Voyager Therapeutics(by analysts ranked 0 to 5 stars)

Based on 16 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Voyager Therapeutics

What analysts predicted

Upside of 197.39%

Current:

$5.75

Target:

$17.10

Insights on Voyager Therapeutics

Price Movement
In the last 3 years, VYGR stock has moved up by 94.9%
Decreasing Revenue
Revenue is down for the last 2 quarters, 29.57M → 24.62M (in $), with an average decrease of 16.7% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -11.33M → -9.04M (in $), with an average increase of 11.9% per quarter
VYGR vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 33.4% return, outperforming this stock by 61.7%
Price to Sales
ForVYGR every $1 of sales, investors are willing to pay $1.9, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.5 for every $1 of sales.

Voyager Therapeutics Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$7.6M	↓ 24.82%
Net Income	$-88.3M	↑ 24.88%
Net Profit Margin	-1.2K%	↓ 461.23%

	FY19	Y/Y Change
Revenue	$104.4M	↑ 1270.14%
Net Income	$-40.8M	↓ 53.75%
Net Profit Margin	-39.11%	↑ 1119.68%

	FY20	Y/Y Change
Revenue	$171.1M	↑ 63.93%
Net Income	$36.7M	↓ 189.98%
Net Profit Margin	21.47%	↑ 60.58%

	FY21	Y/Y Change
Revenue	$37.4M	↓ 78.14%
Net Income	$-66.0M	↓ 279.72%
Net Profit Margin	-176.49%	↓ 197.96%

	FY22	Y/Y Change
Revenue	$40.9M	↑ 9.33%
Net Income	$-46.4M	↓ 29.72%
Net Profit Margin	-113.45%	↑ 63.04%

	FY23	Y/Y Change
Revenue	$250.0M	↑ 511.16%
Net Income	$132.3M	↓ 385.14%
Net Profit Margin	52.93%	↑ 166.38%

	Q2 FY23	Q/Q Change
Revenue	$4.9M	↓ 96.77%
Net Income	$-22.2M	↓ 117.9%
Net Profit Margin	-457.61%	↓ 540.04%

	Q3 FY23	Q/Q Change
Revenue	$4.6M	↓ 4.92%
Net Income	$-25.9M	↑ 16.63%
Net Profit Margin	-561.36%	↓ 103.75%

	Q4 FY23	Q/Q Change
Revenue	$90.1M	↑ 1851.91%
Net Income	$56.4M	↓ 317.73%
Net Profit Margin	62.62%	↑ 623.98%

	Q1 FY24	Q/Q Change
Revenue	$19.5M	↓ 78.33%
Net Income	$-11.3M	↓ 120.09%
Net Profit Margin	-58.05%	↓ 120.67%

	Q2 FY24	Q/Q Change
Revenue	$29.6M	↑ 51.56%
Net Income	$-10.1M	↓ 10.49%
Net Profit Margin	-34.29%	↑ 23.76%

	Q3 FY24	Q/Q Change
Revenue	$24.6M	↓ 16.73%
Net Income	$-9.0M	↓ 10.82%
Net Profit Margin	-36.72%	↓ 2.43%

	FY18	Y/Y Change
Profit	$7.6M	↓ 24.82%

	FY19	Y/Y Change
Profit	$104.4M	↑ 1270.14%

	FY20	Y/Y Change
Profit	$62.4M	↓ 40.25%

	FY21	Y/Y Change
Profit	$37.4M	↓ 40.02%

	FY22	Y/Y Change
Profit	$40.9M	↑ 9.33%

	FY23	Y/Y Change
Profit	$245.6M	↑ 500.31%

	Q2 FY23	Q/Q Change
Profit	$3.8M	↓ 97.48%

	Q3 FY23	Q/Q Change
Profit	$3.7M	↓ 2.6%

	Q4 FY23	Q/Q Change
Profit	$88.7M	↑ 2318.26%

	Q1 FY24	Q/Q Change
Profit	$18.3M	↓ 79.35%

	Q2 FY24	Q/Q Change
Profit	$-4.9M	↓ 126.6%

	Q3 FY24	Q/Q Change
Profit	$24.6M	↓ 605.31%

	FY18	Y/Y Change
Operating Cash Flow	$-15.9M	↓ 74.1%
Investing Cash Flow	$26.5M	↓ 819.02%
Financing Cash Flow	$4.7M	↓ 92.07%

	FY19	Y/Y Change
Operating Cash Flow	$48.7M	↓ 406.33%
Investing Cash Flow	$-90.5M	↓ 441.85%
Financing Cash Flow	$81.0M	↑ 1605.5%

	FY20	Y/Y Change
Operating Cash Flow	$-96.7M	↓ 298.73%
Investing Cash Flow	$113.0M	↓ 224.89%
Financing Cash Flow	$3.2M	↓ 96.09%

	FY21	Y/Y Change
Operating Cash Flow	$-53.5M	↓ 44.66%
Investing Cash Flow	$65.9M	↓ 41.67%
Financing Cash Flow	$612.0K	↓ 80.65%

	FY22	Y/Y Change
Operating Cash Flow	$-12.5M	↓ 76.63%
Investing Cash Flow	$-7.3M	↓ 111.14%
Financing Cash Flow	$1.1M	↑ 81.37%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-835.0K	↓ 100.68%
Investing Cash Flow	$-24.7M	↓ 270.2%
Financing Cash Flow	$1.5M	↓ 95.06%

Voyager Therapeutics Technicals Summary

Sell

Neutral

Buy

Voyager Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Voyager Therapeutics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Voyager Therapeutics, Inc.	6.16%	-29.36%	-32.9%	97.57%	-61.84%
Regeneron Pharmaceuticals, Inc.	-4.72%	-33.43%	-16.35%	14.7%	89.27%
Biontech Se	9.01%	28.55%	5.71%	-57.13%	220.59%
Alnylam Pharmaceuticals, Inc.	-3.99%	7.16%	25.05%	27.48%	103.59%
Vertex Pharmaceuticals Incorporated	-12.1%	-16.49%	-2.12%	78.05%	80.31%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Voyager Therapeutics, Inc.	8.77	8.77	0.0	-0.91	0.1	0.02	NA	6.06
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.05	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Voyager Therapeutics, Inc.	Buy	$316.3M	-61.84%	8.77	15.8%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	89.27%	17.67	33.61%
Biontech Se	Buy	$26.8B	220.59%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.7B	103.59%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$115.2B	80.31%	32.84	-4.51%

About Voyager Therapeutics

voyager therapeutics is a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (cns). voyager is committed to advancing the field of aav (adeno-associated virus) gene therapy through innovation and investment in vector optimization and engineering, dosing techniques, as well as process development and production. the company’s initial pipeline is focused on cns diseases in dire need of effective new therapies, including parkinson’s disease, a monogenic form of amyotrophic lateral sclerosis (als), and friedreich’s ataxia. founded by scientific and clinical leaders in the fields of aav gene therapy, expressed rna interference and neuroscience, voyager therapeutics was launched in 2014 with funding from leading life sciences investor third rock ventures and is headquartered in cambridge, mass. for more information, please visit www.voyagertherapeutics.com.

Organization	Voyager Therapeutics
Employees	162
CEO	Dr. Alfred W. Sandrock Jr., M.D., Ph.D.
Industry	Health Technology

Management People of Voyager Therapeutics

Name	Title
Dr. Alfred W. Sandrock Jr., M.D., Ph.D.	President, CEO & Director
Ms. Robin Swartz	Chief Business Officer & COO
Ms. Jacquelyn Fahey Sandell Esq., J.D.	Chief Legal Officer
Dr. Krystof Bankiewicz M.D., Ph.D.	Founder
Dr. Guangping Gao Ph.D.	Founder & Member of Scientific Advisory Board
Dr. Mark A. Kay M.D., Ph.D.	Founder
Dr. Phillip D. Zamore Ph.D.	Founder & Member of Scientific Advisory Board
Dr. Nathan D. Jorgensen M.B.A., Ph.D.	Chief Financial Officer
Mr. Todd Carter Ph.D.	Chief Scientific Officer
Ms. Michelle Quinn Smith	Chief Human Resources Officer

Important FAQs about investing in Voyager Therapeutics from India :

What is Voyager Therapeutics share price today?

Voyager Therapeutics share price today stands at $5.75, Open: $5.69 ; Previous Close: $5.69 ; High: $5.87 ; Low: $5.53 ; 52 Week High: $11.72 ; 52 Week Low: $5.19. The stock opens at $5.69, after a previous close of $5.69. The stock reached a daily high of $5.87 and a low of $5.53, with a 52-week high of $11.72 and a 52-week low of $5.19.

Can Indians buy Voyager Therapeutics shares?

Yes, Indians can invest in the Voyager Therapeutics (VYGR) from India.

With INDmoney, you can buy Voyager Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Voyager Therapeutics at zero transaction cost.

How can I buy Voyager Therapeutics shares from India?

It is very easy to buy Voyager Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Voyager Therapeutics be purchased?

Yes, you can buy fractional shares of Voyager Therapeutics with INDmoney app.

What are the documents required to start investing in Voyager Therapeutics stocks?

To start investing in Voyager Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.